NNVC - NanoViricides, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue6/30/20186/30/20176/30/20166/30/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development4,826.845,531.7085,028.973,660.322
Selling General and Administrative4,444.8294,069.0163,830.5313,402.778
Non Recurring----
Others----
Total Operating Expenses9,271.6699,600.7248,859.5017,063.1
Operating Income or Loss-9,271.669-9,600.724-8,859.501-7,063.1
Income from Continuing Operations
Total Other Income/Expenses Net708.214-703.766-1,865.1284,864.928
Earnings Before Interest and Taxes-9,271.669-9,600.724-8,859.501-7,063.1
Interest Expense-544.488-2,128.515-2,469.688-3,824.936
Income Before Tax-8,563.455-10,304.49-10,724.629-2,198.172
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-8,563.455-10,304.49-10,724.629-2,198.172
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-8,563.455-10,304.49-10,724.629-2,198.172
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-8,563.455-10,304.49-10,724.629-2,198.172